Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study.
- DOI
- 10.2337/dca26-0039
- Published
- 2026 Sep 21
- Container
- Diabetes care
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2337/dca26-0039,
title = {Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study.},
author = {Cromer SJ and Tesfaye H and Cho H and Wexler DJ and Ortega-Montiel J and Schmedt N and Shay CM and Paik JM and Patorno E},
year = {2026},
journal = {Diabetes care},
doi = {10.2337/dca26-0039},
url = {https://doi.org/10.2337/dca26-0039}
}RIS
TY - JOUR TI - Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study. AU - Cromer SJ AU - Tesfaye H AU - Cho H AU - Wexler DJ AU - Ortega-Montiel J AU - Schmedt N AU - Shay CM AU - Paik JM AU - Patorno E PY - 2026 JO - Diabetes care DO - 10.2337/dca26-0039 UR - https://doi.org/10.2337/dca26-0039 ER -
APA
SJ, C., H, T., H, C., DJ, W., J, O., N, S., CM, S., JM, P., & E, P. (2026). Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study.. Diabetes care. https://doi.org/10.2337/dca26-0039
Source records
- pubmed · retrieved 2026-09-25T07:13:34.323Z
- europe-pmc · retrieved 2026-09-25T07:13:34.301Z